AK Medical Holdings Limited

HKSE 1789.HK

AK Medical Holdings Limited EBT Margin for the year ending December 31, 2023: 21.13%

AK Medical Holdings Limited EBT Margin is 21.13% for the year ending December 31, 2023, a -7.49% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

AK Medical Holdings Limited EBT Margin for the year ending December 31, 2022 was 22.84%, a 60.20% change year over year.
AK Medical Holdings Limited EBT Margin for the year ending December 31, 2021 was 14.26%, a -60.80% change year over year.
AK Medical Holdings Limited EBT Margin for the year ending December 31, 2020 was 36.37%, a 4.88% change year over year.
AK Medical Holdings Limited EBT Margin for the year ending December 31, 2019 was 34.68%, a 19.36% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

HKSE: 1789.HK

AK Medical Holdings Limited

CEO	Mr. Zhijiang Li
IPO Date	Dec. 20, 2017
Location	China
Headquarters	Xingye Building
Employees	974
Sector	Technology
Industries 3D Printing Automotive Parts Composite Materials Furniture Medical Instruments Pharmaceuticals Plastics Robotics

Description

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

Key trends

Past 5 years